Abstract
There is a long history of using traditional Chinese medicine in the treatment of liver cancer and other malignnancies. The classification of Qi stagnation and blood stasis (QSBS) is the most common Zheng in liver cancer. This Zheng is frequently encountered in liver cancers falling into the pathological category of massive type. QSBS is the principal mechanism for a tumor to develop. Liver cancer with QSBS Zheng has characteristic clinical manifestations. Evidence from ex vivo, in vivo and clinical studies has been reported for the identification and management of liver cancer with QSBS Zheng. This article reviews evidence-based study advances of QSBS Zheng, the most common Zheng encountered in liver cancer.
Highlights
Liver cancer is one of the leading causes of cancer death worldwide [1]
Complementary and alternative medicines are actively sought for this purpose [6], among them, traditional Chinese medicine (TCM) is well known for its long history of application in both treatable and incurable diseases in Asia and the West
This article reviews evidence-based study advances of Qi stagnation and blood stasis (QSBS) Zheng, the most common Zheng encountered in liver cancer
Summary
Liver cancer is one of the leading causes of cancer death worldwide [1]. Several therapeutic modalities have been used for its management [2], but satisfactory results are infrequently obtained [3]. Some TCM therapy based on evidence has been reported yielding unexpectedly good results in treatment of liver cancer [7]. A TCM Zheng is in dynamic change caused by multiple correlative factors [10]. It is the highly condensed summing-up of the etiology, nature, location and tendency of a certain disease at a particular stage [11], and indicates the essence of the disease to some extent as the basis of clinical management [12]. According to a modern nomination system, the name of a TCM Zheng (or syndrome pattern) consists of two or more syndrome elements (or factors) which fall into two categories: the nature, and the location of the disease [13]. Article reviews evidence-based study advances of QSBS Zheng, the most common Zheng encountered in liver cancer
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
